INTRODUCTION
Chronic granulomatous disease (CGD)' is characterized by a defect in the polymorphonuclear leukocyte (PMNL) production of superoxide anion (1) , hydrogen peroxide, singlet oxygen, and hydroxyl radicals (2, 3) . These oxygen species contribute to leukocyte-mediated bacterial killing (2, 3) and their absence is generally believed to account for the impaired ability of patients with CGD to resist certain bacterial infections (4) .
In addition to a bactericidal activity, active oxygen species can stimnulate the peroxidation of unsaturated lipids. Superoxide-generating systems have been used to oxidize plasma lipids (5) as well as arachidonic acid in vitro (6, 7) to produce chemotactic substances. In a careful chemical analysis of arachidonic acid cooxidation by superoxide-dependent oxidants, Fridovich and Porter (7) found 5-hydroperoxy-eicosatetraenoic acid to predominate. 5-Hydroperoxy-eicosatetraenoic acid can also be generated enzymatically by human PMNL (8) . This hydroperoxide is further converted via an unstable epoxide to the leukotrienes (9), a novel group of metabolites which appear to play an important ' Abbreviations used in this paper: CGD, chronic granulomatous disease; HPLC, high performance liquid chromatography; LTB4, leukotriene B4, 5(S),12(R)-dihydroxy -6,14-cis-8,10-trans-eicosatetraenoic acid; PMNL, polymorphonuclear leukocytes; 5(S),12(S)-DHETE, 5(S),12(S)-role in inflammation. 5(S),12(R)-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid (leukotriene B4; LTB4) has been shown to stimulate human PMNL chemotaxis (10, 11) , degranulation (12) , and adherence (13) . Other leukotrienes have potent biological activities as well, including leukotriene C4 and its metabolites, previously known as the slow-reacting substances (see reference 14 for review).
Since leukocytes synthesize oxidized lipids which are chemotactically potent as well as activated oxygen species at levels sufficient to oxidize unsaturated fatty acids, a strong parallel exists between the in vitro systems mentioned above and the stimulated leukocyte. These data suggest that a superoxide-dependent oxidant may directly attack arachidonate to yield the hydroperoxy acid precursors to the leukotrienes. This chemical oxidation has been calculated to adequately account for the total production of oxidized lipids by PMNL under certain conditions (15) . Alternatively, the production of the hydroperoxy acid leukotriene precursors has, itself, been proposed to be a significant source of active oxygen species through decomposition of the peroxide (16). The absence of superoxide anion production in the leukocytes of CGD patients, therefore, offers a unique opportunity to resolve the interaction between this active molecule (and its consequent oxidants) and arachidonic acid lipoxygenation. In these studies, PMNL were obtained from two patients previously characterized as suffering from CGD. The metabolic activity of these cells in oxidizing arachidonic acid to leukotrienes was assessed. At the same time, the ability of these leukocytes to generate superoxide anion in response to LTB4 stimulation was determined in a chemiluminescence assay.
METHODS
Patients. Patient 1, a 30-yr-old male, has suffered from recurrent severe bacterial infections (primarily due to Staphylococcus aureus) since childhood (17, 18) . Previous studies have shown that his PMNL do not reduce nitroblue tetrazolium nor do they increase their oxygen consumption upon stimulation. These cells exhibited reduced bactericidal capacity, but had normal staining characteristics for myeloperoxidase and alkaline phosphatase.
Patient 2, a 37-yr-old male, had recurrent pneumonias and sinusitis during childhood. His major adult infections have been recurrent or chronic gingivitis and skin infections. Previous studies showed that his PMNL gave only marginal nitroblue tetrazolium reduction and exhibited a markedly reduced bactericidal activity; his serum immunoglobulins and complement factors, serum opsonin function, and in vitro lymphocyte reactivity were all normal.
The present investigations occurred while both patients were apparently healthy and disclosed reduced bactericidal activity and normal ultrastructure of PMNL by electron microscopy. PMNL Preparation. Blood was obtained from healthy donors of both sexes and from two male CGD patients during infection-and drug-free intervals. After venipuncture, blood was allowed to drip into plastic tubes containing either EDTA (final concentration 7.7 mM) or heparin (final concentration 10 IU/ml).
Leukocytes for chemiluminescence assays were prepared from heparinized blood by dextran sedimentation and repeated saline washes (19) The cells were incubated with arachidonic acid and A23187 as detailed above and the leukotrienes were extracted and purified by silicic acid column chromatography. Nearly identical amounts of the extracted radioactivity were recovered in the leukotriene fraction from both control (4.8%) and patient (4.7%) leukocyte incubations. The leukotrienes were further purified by HPLC. The final analytical step was separation of the purified leukotriene methyl esters by straight-phase HPLC. The production of four major arachidonic acid metabolites was confirmed. PMNL derived from the CGD patients were capable of synthesizing LTB4, 6- trans-LTB4, 12-epi-6-trans-LTB4, and 5(S),12(S)-dihydroxy-6, 10-trans-8, 1 4-cis-eicosatetraenoic acid (5(S),12(S)-DHETE) (Fig. 1) . These experiments lead us to suggest that there are no differences in the quantities of these dihydroxy acids produced by CGD or normal PMNL.
The monohydroxy acids derived from arachidonate were also analyzed. There were no qualitative differences between CGD and normal PMNL products. In addition, similar levels of 5-, 12-, and 15-hydroxy-eicosatetraenoic acid were synthesized by both patient and control leukocyte preparations.
Chemiluminescence. Leukocytes obtained from a group of normal volunteers produced a distinct burst of chemiluminescence when challenged with either formyl-methionyl-leucyl-phenylalanine or LTB4 (Table  I) . However, PMNL of both CGD patients failed to respond when stimulated under identical conditions. 
DISCUSSION
The clinical diagnosis of chronic granulomatous disease in both patients was confirmed biochemically. PMNL from the patients did not produce chemiluminescence after appropriate stimulation. This indicates that active oxygen species, including superoxide anion, were not formed.
Leukotrienes and Chronic Granulomatous Disease In contrast to the deficient leukocyte respiratory burst, PMNL from both patients were able to synthesize the same range and level of mono-and dihydroxyarachidonic acid metabolites as control cells. This includes the biologically active leukotriene, LTB4, which activates PMNL in vitro.
These studies allow a clear separation of leukotriene biosynthesis from leukocyte-generated active oxygen species. The presence of superoxide anion and its consequent oxidants is not a prerequisite to leukotriene formation. Furthermore, the oxidative metabolism of arachidonate via hydroperoxide intermediates does not contribute significantly to the formation of chemiluminescent oxygen species.
Finally, the inadequacy of CGD neutrophil bactericidal activity is not due to a failure to oxidize arachidonic acid to LTB4. The possibility that the defect of this disease is related to the cellular response to leukotrienes rather than leukotriene synthesis is currently under investigation.
